Diagnostic options · UAE

Genetics tests in Dubai & UAE

Compare available Genetics tests, their listed prices and the information provided for each option. Test selection and preparation should be discussed with your clinician.

Tests in this category

2,789

Listed price range

-1.00–50,000.00 AED

Clinical preparation

Confirm test-specific instructions with your clinician or laboratory.

Compare available tests

Genetics test prices

Showing 271–285 of 2,789 matching tests.

Genetics diagnostic tests, details, and listed prices
Test and description	Specimen	Typical duration	Price	Options
TEST-3889 BBS9 Gene Bardet-Biedl Syndrome Type 9 Genetic Test This test detects pathogenic variants in the BBS9 gene associated with Bardet-Biedl syndrome type 9.	Peripheral whole blood, extracted DNA, or one drop blood on FTA card	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the BBS9 gene", "Full gene coverage including deep intronic regions and CNV detection"] Parameters [] Preparation [] Indications ["Clinical suspicion of Bardet-Biedl syndrome type 9", "Known familial pathogenic variant"] Measurement technique Confirm with laboratory Codes LOINC: 81247-8 ICD-10: Q87.8, Z15.89, Z13.7 Clinical summary This test detects pathogenic variants in the BBS9 gene associated with Bardet-Biedl syndrome type 9.
TEST-5577 BCAP31 Gene Test (X‑Linked Deafness, Dystonia, and Cerebral Hypomyelination) This diagnostic test evaluates the BCAP31 gene for pathogenic variants associated with X-linked deafness-dystonia-cerebral hypomyelination syndrome.	Whole Blood, Cheek Swab, or Dried Blood Spot	3–4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["BCAP31 gene pathogenic variants", "Copy Number Variations (CNVs) in BCAP31"] Parameters [] Preparation ["Mandatory pre-test genetic counselling session required"] Indications ["Males with clinical features suggestive of the syndrome", "Carrier females with a positive family history", "Confirmation of clinical diagnosis"] Measurement technique Confirm with laboratory Codes LOINC: 81247-9 ICD-10: Q87.8, H90.5, G24.9 Clinical summary This diagnostic test evaluates the BCAP31 gene for pathogenic variants associated with X-linked deafness-dystonia-cerebral hypomyelination syndrome.
TEST-6043 BCAT1 Gene Branched-Chain Aminotransferase 1 Deficiency Genetic Test This genetic test identifies pathogenic variants in the BCAT1 gene, confirming a diagnosis of Branched-Chain Aminotransferase 1 Deficiency.	Whole Blood, Buccal Swab, or FTA Card	3 to 4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["BCAT1 gene sequence", "Pathogenic variants in BCAT1 gene"] Parameters [] Preparation ["No specific fasting required", "Do not discontinue prescribed medication"] Indications ["Clinical suspicion of branched-chain amino acid metabolism disorders", "Unexplained developmental delay", "Neurological deterioration", "Family history of BCAT1 deficiency"] Measurement technique Confirm with laboratory Codes LOINC: 87712-1 ICD-10: E71.1 Clinical summary This genetic test identifies pathogenic variants in the BCAT1 gene, confirming a diagnosis of Branched-Chain Aminotransferase 1 Deficiency.
TEST-6147 BCAT2 Gene Branched-Chain Aminotransferase 2 Deficiency Genetic Test This genetic test identifies pathogenic variants in the BCAT2 gene associated with branched-chain aminotransferase 2 deficiency.	Whole blood, FTA card blood spot, or extracted DNA	3–4 weeks from sample receipt	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the BCAT2 gene"] Parameters [] Preparation [] Indications ["Individuals with unexplained metabolic symptoms", "Family history of BCAT2 deficiency", "Proactive health and longevity strategies"] Measurement technique Confirm with laboratory Codes LOINC: 94233-3 ICD-10: E71.8 Clinical summary This genetic test identifies pathogenic variants in the BCAT2 gene associated with branched-chain aminotransferase 2 deficiency.
TEST-6051 BCHE Gene Butyrylcholinesterase Deficiency Genetic Test This genetic test evaluates the BCHE gene for mutations associated with butyrylcholinesterase deficiency, an inherited condition affecting anesthetic metabolism.	Whole Blood, Extracted DNA, Dried Blood Spot (FTA Card)	3–4 Weeks (21–28 Calendar Days)	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["BCHE gene sequence", "Pathogenic mutations in the BCHE gene"] Parameters [] Preparation ["No fasting required", "No specific medication or diet restrictions"] Indications ["Preoperative screening for patients undergoing surgery requiring succinylcholine or mivacurium", "Evaluation of individuals with a family history of pseudocholinesterase deficiency", "Diagnosis of unexplained prolonged paralysis following anesthesia"] Measurement technique Confirm with laboratory Codes LOINC: 21671-0 ICD-10: E70.3 Clinical summary This genetic test evaluates the BCHE gene for mutations associated with butyrylcholinesterase deficiency, an inherited condition affecting anesthetic metabolism.
TEST-1841 BCL2 Gene Rearrangement, FISH Test This test detects rearrangements in the BCL2 gene, commonly associated with follicular lymphoma and other B-cell malignancies.	Bone Marrow / Peripheral Blood	3–4 business days	700.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["BCL2 gene rearrangement", "t(14;18) translocation"] Parameters [] Preparation ["No fasting required", "Inform phlebotomist about medications or bleeding conditions", "Arrange for a companion if bone marrow aspiration is performed"] Indications ["Suspected lymphoma", "Diagnosis of follicular lymphoma", "Risk stratification", "Monitoring minimal residual disease"] Measurement technique Confirm with laboratory Codes LOINC: 48532-1 ICD-10: C82.9 Clinical summary This test detects rearrangements in the BCL2 gene, commonly associated with follicular lymphoma and other B-cell malignancies.
TEST-1835 BCL2/IGH (t14;18) Translocation FISH Test This diagnostic test evaluates for the presence of the BCL2/IGH (t14;18) chromosomal translocation in tumor tissue using FISH.	Archival Tissue Specimen (FFPE tissue blocks or slides)	7–8 working days	1,200.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["BCL2/IGH (t14;18) chromosomal translocation", "Gene rearrangement"] Parameters [] Preparation ["No fasting required", "No specific medication adjustments needed unless advised by physician"] Indications ["Suspected diagnosis of follicular lymphoma", "Monitoring for minimal residual disease", "Therapeutic stratification"] Measurement technique Confirm with laboratory Codes LOINC: 87783-7 ICD-10: C82.9 Clinical summary This diagnostic test evaluates for the presence of the BCL2/IGH (t14;18) chromosomal translocation in tumor tissue using FISH.
TEST-2770 BCL9L Gene Heterotaxy, Visceral, BCL9L Related Genetic Test This genetic test analyzes the BCL9L gene for pathogenic variants associated with visceral heterotaxy and congenital laterality defects.	Peripheral Whole Blood	3 to 4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the BCL9L gene"] Parameters [] Preparation ["No specific fasting required", "Inform lab of any medications"] Indications ["Neonates, children, or adults with congenital heart defects", "Individuals with situs inversus", "Family history of visceral laterality disorders"] Measurement technique Confirm with laboratory Codes LOINC: 104143-7 ICD-10: Q20.3 Clinical summary This genetic test analyzes the BCL9L gene for pathogenic variants associated with visceral heterotaxy and congenital laterality defects.
TEST-3034 BCS1L Gene (Björnstad Syndrome) Genetic Test This test identifies pathogenic variants within the BCS1L gene, confirming a diagnosis of Björnstad syndrome.	Peripheral whole blood (EDTA) or FTA card	3–4 weeks from sample receipt	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the BCS1L gene", "Presence of mutations causing Björnstad syndrome"] Parameters [] Preparation [] Indications ["Clinical suspicion of Björnstad syndrome", "Confirmation of diagnosis in children and adults", "Family member assessment for inheritance risk"] Measurement technique Confirm with laboratory Codes LOINC: 55233-1 ICD-10: Q84.1, H90.3 Clinical summary This test identifies pathogenic variants within the BCS1L gene, confirming a diagnosis of Björnstad syndrome.
TEST-2812 BCS1L Gene GRACILE Syndrome Genetic Test This test identifies pathogenic variants in the BCS1L gene associated with GRACILE syndrome.	Whole Blood (EDTA), DNA Extract, or FTA Card	3 to 4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the BCS1L gene"] Parameters [] Preparation ["No fasting required", "Prior genetic counseling session advised"] Indications ["Suspected GRACILE syndrome based on clinical presentation", "Family history of GRACILE syndrome", "Neonatal screening results suggesting mitochondrial disorder"] Measurement technique Confirm with laboratory Codes LOINC: 81247-9 ICD-10: E88.49 Clinical summary This test identifies pathogenic variants in the BCS1L gene associated with GRACILE syndrome.
TEST-4704 BCS1L Gene Leigh Syndrome Genetic Test This genetic test identifies pathogenic variants within the BCS1L gene associated with Leigh syndrome.	Whole Blood, Extracted DNA, or FTA Card	3 to 4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the BCS1L gene", "Mitochondrial function related to BCS1L protein"] Parameters [] Preparation ["No specific fasting required.", "Inform the phlebotomist of any current medications."] Indications ["Suspected Leigh syndrome based on clinical presentation", "Family history of Leigh syndrome or related mitochondrial disorders", "Need for definitive molecular diagnosis to guide treatment and counselling"] Measurement technique Confirm with laboratory Codes LOINC: 88312-2 ICD-10: G31.82 Clinical summary This genetic test identifies pathogenic variants within the BCS1L gene associated with Leigh syndrome.
TEST-5787 BEAN1 Gene Spinocerebellar Ataxia Type 31 (SCA31) Genetic Test This genetic test detects pathogenic repeat expansions and variants in the BEAN1 gene associated with Spinocerebellar Ataxia Type 31 (SCA31).	Whole blood (EDTA), extracted DNA, or FTA card (dried blood spot)	3–4 weeks from sample collection	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic pentanucleotide repeat expansions in the BEAN1 gene", "Other pathogenic variants in the BEAN1 gene"] Parameters [] Preparation ["No specific fasting required", "Inform lab of any relevant medications"] Indications ["Suspected diagnosis of SCA31 based on clinical presentation", "Family history of SCA31", "Need for definitive diagnosis for management and genetic counseling", "Pre-symptomatic or predictive testing in at-risk individuals"] Measurement technique Confirm with laboratory Codes LOINC: 81247-9 ICD-10: G11.0 Clinical summary This genetic test detects pathogenic repeat expansions and variants in the BEAN1 gene associated with Spinocerebellar Ataxia Type 31 (SCA31).
TEST-2158 Beckwith‑Wiedemann Syndrome (11p15) Genetic Test This test evaluates the 11p15 imprinting region for genetic and epigenetic alterations associated with Beckwith‑Wiedemann Syndrome.	Whole Blood (EDTA), FTA Card, or Extracted DNA	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["11p15 IC1/IC2 methylation status", "CDKN1C variants", "H19 variants", "KCNQ1OT1 variants", "Genome-wide copy number variations (CNV)"] Parameters [] Preparation [] Indications ["Clinical suspicion of Beckwith‑Wiedemann Syndrome", "Evaluation of overgrowth syndromes", "Prenatal screening for BWS features", "Family history of BWS"] Measurement technique Confirm with laboratory Codes LOINC: 81254-5 ICD-10: Q87.3 Clinical summary This test evaluates the 11p15 imprinting region for genetic and epigenetic alterations associated with Beckwith‑Wiedemann Syndrome.
TEST-1809 Beta Thalassemia (9 Common Mutations) Screening Test This test identifies the presence of 9 common mutations associated with beta-thalassemia using molecular methods.	Peripheral whole blood	3–4 working days	700.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Presence of specific beta-globin gene mutations"] Parameters [] Preparation ["No specific fasting required", "Inform the lab about any recent blood transfusions (within 12 weeks)"] Indications ["Carrier screening", "Preconception risk assessment", "Prenatal genetic counseling", "Individuals with unexplained microcytic anemia"] Measurement technique Confirm with laboratory Codes LOINC: 49519-1 ICD-10: Z13.0 Clinical summary This test identifies the presence of 9 common mutations associated with beta-thalassemia using molecular methods.
TEST-1810 Beta Thalassemia HBB Deletion/Duplication Analysis Test This diagnostic test evaluates the HBB gene for large deletions or duplications associated with beta-thalassemia syndromes.	Peripheral Whole Blood (standard); Cord Blood, Amniotic Fluid, Chorionic Villi (hospital collection required)	7–10 Business Days	1,400.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Copy number variations (deletions/duplications) in the HBB gene", "Presence of large genomic rearrangements"] Parameters [] Preparation ["Inform phlebotomist about anticoagulant, antiplatelet, or iron chelation therapy.", "Continue all prescribed medications unless directed otherwise by a specialist."] Indications ["Diagnostic confirmation of beta-thalassemia", "Family cascade screening", "Prenatal planning", "Identification of silent carriers", "Confirmation of hereditary persistence of fetal hemoglobin (HPFH)"] Measurement technique Confirm with laboratory Codes LOINC: 21665-2 ICD-10: D56.1 Clinical summary This diagnostic test evaluates the HBB gene for large deletions or duplications associated with beta-thalassemia syndromes.

Category overview

Genetics: overview

Understanding your unique biological blueprint offers a profound sense of clarity and empowers proactive health planning for you and your family. At DNA Labs UAE, our specialized Genetics division employs state-of-the-art molecular technologies to provide deep insights into hereditary markers and cellular mutations. This comprehensive genetics testing in the UAE equips your healthcare provider with the precise data needed to tailor your medical guidance effectively. Recognized among top diagnostic labs in Dubai and the UAE, we prioritize your peace of mind through strict confidentiality protocols and exceptionally fast, accurate reporting. Take the next step in your health journey. View our genetics diagnostic services, book a private home collection, or consult our specialized team today.

Before booking

Use the test details as a conversation starter

The right diagnostic option depends on your reason for testing and individual circumstances. Check the listed specimen and timing, then confirm any preparation requirements with the ordering clinician or laboratory before collection.

Explore this area

Genetics tests in Dubai & UAE

Genetics test prices

Genetics: overview

Use the test details as a conversation starter

Related Genetics categories